Cure Lab Oncology Names Dr. Aubrey C. Galloway As Chief Medical Officer
07/11/24, 10:12 AM
Location
dedhamIndustry
biotechnology
Position
chief medical officer
CureLab Oncology has appointed Dr Aubrey C Galloway as chief medical officer, a strategic move following his recent addition to the company's scientific advisory board. Dr Galloway, a renowned cardiac surgeon and the Seymour Cohn Professor of Cardiothoracic Surgery at NYU Langone Health, brings extensive expertise in clinical trials, cardiovascular disease research, and an understanding of host inflammatory mediators of a variety of inflammatory diseases to this new position at CureLab Oncology.
Company Info
Location
417 greenlodge street
dedham, iowa, united states
Additional Info
CureLab Oncology Inc. is a clinical-stage biotech company headquartered in the greater Boston area, Massachusetts. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab's lead investigational compound is code-named Elenagen, an experimental DNA therapy that consists of a circular piece of DNA called a plasmid that includes a gene for a human protein called p62/SQSTM1.